Cargando…

Editorial: Role of the serotonergic system in pathology of major depressive disorders

Detalles Bibliográficos
Autor principal:	Norman, Trevor Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393722/ https://www.ncbi.nlm.nih.gov/pubmed/36003982 http://dx.doi.org/10.3389/fpsyt.2022.988307

Ejemplares similares

Editorial: Role of serotonergic system in pathology of major depressive disorders
por: Fakhfouri, Gohar, et al.
Publicado: (2022)

Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders
por: Liu, Yi, et al.
Publicado: (2019)

Editorial: Basic and clinical research on neurostimulation techniques in major depressive disorder
por: Liu, Chaomeng, et al.
Publicado: (2023)

The roles of extracellular vesicles in major depressive disorder
por: Li, Ying, et al.
Publicado: (2023)

Histamine and histamine receptors: Roles in major depressive disorder
por: Qian, Hong, et al.
Publicado: (2022)

A Review of the Role of Social Cognition in Major Depressive Disorder
por: Weightman, Michael James, et al.
Publicado: (2014)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
por: Barlati, Stefano, et al.
Publicado: (2023)

Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
por: Gay, Florian, et al.
Publicado: (2022)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

Editorial: CBASP in the Treatment of Persistent Depressive Disorder
por: Wiersma, Jenneke, et al.
Publicado: (2021)

Cortical Inhibition and Plasticity in Major Depressive Disorder
por: Castricum, Jesminne, et al.
Publicado: (2022)

Eye Movement Abnormalities in Major Depressive Disorder
por: Takahashi, Junichi, et al.
Publicado: (2021)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Editorial: Neural circuits and neuroendocrine mechanisms of major depressive disorder and premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
por: Wei, Sheng, et al.
Publicado: (2022)

Role of Electroconvulsive Therapy in Major Depressive Disorder with Borderline Personality Disorder: Case Report and Literature Review
por: Wasiq, Saad, et al.
Publicado: (2018)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Editorial: Brain serotonergic system
por: Mouradian, Gary C., et al.
Publicado: (2023)

Rewiring of the Serotonin System in Major Depression
por: Vahid-Ansari, Faranak, et al.
Publicado: (2021)

The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder
por: Liberg, Benny, et al.
Publicado: (2015)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder
por: Zuckerman, Hannah, et al.
Publicado: (2018)

Review of Abnormal Self-Knowledge in Major Depressive Disorder
por: Lou, Yixue, et al.
Publicado: (2019)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Gender Differences in Dysfunctional Attitudes in Major Depressive Disorder
por: Qin, Xuemei, et al.
Publicado: (2020)

Pineal Gland Volume in Major Depressive and Bipolar Disorders
por: Takahashi, Tsutomu, et al.
Publicado: (2020)

Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
por: Sarawagi, Ajay, et al.
Publicado: (2021)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Editorial: Reducing the Mortality Gap in People With Severe Mental Disorders: The Role of Lifestyle Psychosocial Interventions
por: Fiorillo, Andrea, et al.
Publicado: (2019)

Editorial: Addressing the challenges in the diagnosis of depressive disorder in children and adolescents
por: Lee, Moon-Soo, et al.
Publicado: (2022)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021)

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Disrupted Structural Brain Network Organization Behind Depressive Symptoms in Major Depressive Disorder
por: Liu, Jing, et al.
Publicado: (2020)

Aberrant degree centrality of functional brain networks in subclinical depression and major depressive disorder
por: Yang, Lei, et al.
Publicado: (2023)

Basic psychological need satisfaction and frustration in major depressive disorder
por: Pietrek, Anou, et al.
Publicado: (2022)

Reduced Intrinsic Connectivity of Amygdala in Adults with Major Depressive Disorder
por: Ramasubbu, Rajamannar, et al.
Publicado: (2014)

Major Depressive Disorder Alters Perception of Emotional Body Movements
por: Kaletsch, Morten, et al.
Publicado: (2014)

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
por: Young, Juan Joseph, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vpksmshiqn2g947ml7jkva9hjp